Cervical cancer study pulled before it began: no patients enrolled
NCT ID NCT06866951
First seen Jan 03, 2026 · Last updated Jun 18, 2026 · Updated 23 times
Summary
This study was designed to see if adding immunotherapy to chemotherapy works better than the usual chemoradiotherapy for cervical cancer patients whose cancer had spread to lymph nodes after surgery. The plan was to enroll about 50 patients and track cancer return rates over three years. However, the study was withdrawn before any patients joined, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Womens' Hosptial, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310000, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.